英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

porphyritic    音标拼音: [p,ɔrfɚ'ɪtɪk]
a. 斑岩的

斑岩的



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Vivani
    Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and… Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the…
  • Press Releases :: Vivani Medical, Inc. (VANI)
    Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026 Nov 13, 2025 7:45am EST Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results Oct 28, 2025 4:05pm EDT Vivani Medical, Inc Announces Closing of Common Stock Offering Oct 26, 2025 7:15pm EDT
  • Careers - Vivani
    To make real progress in advancing life-changing therapeutic treatments, we must show relentless dedication to finding new, creative solutions to existing problems Though this need creates a challenging and fast-paced environment, we strive to ensure everyone has fun in the process Our management style not only helps keep the team engaged and energized, but it also fosters relationships
  • Vivani - Vivani
    Vivani™ is an innovative, clinical stage biopharmaceutical company Leveraging our proprietary NanoPortal™ platform technology, we are developing a portfolio of miniature, long-term drug implants to address two main barriers of optimal chronic disease treatment: poor medication adherence and tolerability
  • Our Company :: Vivani Medical, Inc. (VANI)
    Vivani Medical is an emerging biopharmaceutical company developing a pipeline of miniature, long-term, subdermal, drug implants with its proprietary NanoPortal™ technology Vivani’s lead assets, NPM-115 and NPM-119, are miniature, six-month, GLP-1 (exenatide) implants under development for chronic weight management obesity and type 2 diabetes, respectively NPM-115 and NPM-119 are designed
  • Portfolio - Vivani
    Leveraging our NanoPortal ™ technology, we are developing a portfolio of highly differentiated products comprised of miniature, sub-dermal drug implants
  • Investors :: Vivani Medical, Inc. (VANI)
    Vivani Medical is an emerging biopharmaceutical company developing a pipeline of miniature, long-term drug implants with its proprietary NanoPortal™ platform technology for obesity weight management and other chronic diseases Vivani’s lead…
  • Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation . . .
    About Vivani Medical, Inc Leveraging its proprietary NanoPortal™ platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication
  • Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM . . .
    Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
  • Vivani Medical Provides Business Update and Reports Third Quarter 2025 . . .
    About Vivani Medical, Inc Leveraging its proprietary NanoPortal™ platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence and improving patient tolerance to their medication





中文字典-英文字典  2005-2009